Supernus Pharma (SUPN) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. AMZN

Go back to Supernus Pharma (SUPN) Tops Q3 EPS by 1c

Stifel Upgrades Supernus Pharmaceuticals (SUPN) to Buy, Would be Buyer On Weakness

November 8, 2017 4:30 AM EST

Stifel upgraded Supernus Pharmaceuticals (NASDAQ: SUPN) from Hold to Buy with a price target of $47.00.

Analyst Annabel Samimy believes with the cash and balance sheet flexibility available to management, the company is well funded to pursue its growth programs which amplifies its... More